Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP

Journal of Nanobiotechnology

Volumn 11, Issue 1, 2013, Pages

  Babin, Cindy ^a   Majeau, Nathalie ^a   Leclerc, Denis ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Influenza; Papaya mosaic virus (PapMV); Rod shape nanoparticles; Vaccine platform

Indexed keywords

DRIVING FORCES; IMMUNOGENICITY; INFECTIOUS DISEASE; INFLUENZA; INFLUENZA PANDEMICS; INFLUENZA VIRUS; MOSAIC VIRUS; PROOF OF CONCEPT;

NANOPARTICLES; PEPTIDES; RNA; VACCINES; VIRUSES;

EPITOPES;

COAT PROTEIN; EPITOPE; NANOPARTICLE; PAPAYA MOSAIC VIRUS VACCINE; RNA; UNCLASSIFIED DRUG; VIRUS VACCINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA VIRUS; MOUSE; NONHUMAN; VIRUS NUCLEOCAPSID;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; CARICA; CLONING, MOLECULAR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES, T-LYMPHOCYTE; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MOSAIC VIRUSES; NANOPARTICLES; NUCLEOCAPSID; PEPTIDES; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

MUS; ORTHOMYXOVIRIDAE; PAPAYA MOSAIC VIRUS;

EID: 84875689802     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-11-10     Document Type: Article

References (27)

1. Sit TL, Abouhaidar MG, Holy S. Nucleotide sequence of papaya mosaic virus RNA. J Gen Virol 1989, 70:2325-2331. 10.1099/0022-1317-70-9-2325, 2778435.
2. Yang S, Wang T, Bohon J, Laliberté-Gagné ME, Bolduc M, Leclerc D, Li H. Crystal structure of the coat protein of the flexible filamentous papaya mosaic virus. J Mol Biol 2012, 422:263-273. 10.1016/j.jmb.2012.05.032, 22659319.
3. Tremblay MH, Majeau N, Laliberté-Gagné ME, Lecours K, Morin H, Duvignaud J-B, Bolduc M, Chouinard N, Paré C, Gagné S, Leclerc D. Effect of mutations K97A and E128A on RNA binding and self assembly of papaya mosaic potexvirus coat protein. FEBS J 2006, 273:14-25. 10.1111/j.1742-4658.2005.05033.x, 16367744.
4. Denis J, Majeau N, Acosta-Ramirez E, Savard C, Bedard M-C, Simard S, Lecours K, Bolduc M, Pare C, Willems B, Shoukry N, Tessier P, Lacasse P, Lamarre A, Lapointe R, Lopez Macias C, Leclerc D. Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: Evidence for the critical function of multimerization. Virology 2007, 363:59-68. 10.1016/j.virol.2007.01.011, 17320136.
5. Denis J, Acosta-Ramirez E, Zhao Y, Hamelin M-E, Koukavica I, Baz M, Abed Y, Savard C, Pare C, Lopez Macias C, Boivin G, Leclerc D. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine 2008, 26:3395-3403. 10.1016/j.vaccine.2008.04.052, 18511159.
6. Leclerc D, Beauseigle D, Denis J, Morin H, Pare C, Lamarre A, Lapointe R. Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells. J Virol 2007, 81:1319-1326. 10.1128/JVI.01720-06, 1797532, 17121795.
7. Lacasse P, Denis J, Lapointe R, Leclerc D, Lamarre A. Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation. J Virol 2008, 82:785-794. 10.1128/JVI.01811-07, 2224570, 17989184.
8. Rioux G, Babin C, Majeau N, Leclerc D. Engineering of papaya mosaic virus (PapMV) nanoparticles through fusion of the HA11 peptide to several putative surface-exposed sites. PLoS One 2012, 7:e31925. 10.1371/journal.pone.0031925, 3283703, 22363771.
9. Hanafi L-A, Bolduc M, Gagné MEL, Dufour F, Langelier Y, Boulassel M-R, Routy J-P, Leclerc D, Lapointe R. Two distinct chimeric potexviruses share antigenic cross-presentation properties of MHC class I epitopes. Vaccine 2010, 28:5617-5626. 10.1016/j.vaccine.2010.06.024, 20600515.
10. Morin H, Tremblay MH, Plante E, Paré C, Majeau N, Hogue R, Leclerc D. High avidity binding of engineered papaya mosaic virus virus-like particles to resting spores of Plasmodiophora Brassicae. J Biotechnology 2007, 128:423-434.
11. Bachmann M, Rohrer U, Kundig T, Burki K, Hengartner H, Zinkernagel R. The influence of antigen organization on B cell responsiveness. Science 1993, 1993(262):1448-1451.
12. Jegerlehner A, Storni T, Lipowsky G, Schmid M, Pumpens P, Bachmann MF. Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation. Eur J Immunol 2002, 32:3305-3314. 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J, 12555676.
13. Middelberg APJ, Rivera-Hernandez T, Wibowo N, Lua LHL, Fan Y, Magor G, Chang C, Chuan YP, Good MF, Batzloff MR. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines. Vaccine 2011, 29:7154-7162. 10.1016/j.vaccine.2011.05.075, 21651936.
14. Laliberté Gagné ME, Lecours K, Gagné S, Leclerc D. The F13 residue is critical for interaction among the coat protein subunits of papaya mosaic virus. FEBS J 2008, 275:1474-1484. 10.1111/j.1742-4658.2008.06306.x, 18312419.
15. Barbalat R, Ewald SE, Mouchess ML, Barton GM. Nucleic acid recognition by the innate immune system. Annu Rev Immunol 2011, 29:185-214. 10.1146/annurev-immunol-031210-101340, 21219183.
16. Desmet CJ, Ishii KJ. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol 2012, 12:479-491. 10.1038/nri3247, 22728526.
17. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820. 10.1016/j.cell.2010.01.022, 20303872.
18. Plchova H, Moravec T, Hoffmeisterova H, Folwarczna J, Cerovska N. Expression of Human papillomavirus 16 E7ggg oncoprotein on N- and C-terminus of Potato virus X coat protein in bacterial and plant cells. Protein Expr Purif 2011, 77:146-152. 10.1016/j.pep.2011.01.008, 21266198.
19. Lico C, Mancini C, Italiani P, Betti C, Boraschi D, Benvenuto E, Baschieri S. Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice. Vaccine 2009, 27:5069-5076. 10.1016/j.vaccine.2009.06.045, 19563889.
20. Lico C, Capuano F, Renzone G, Donini M, Marusic C, Scaloni A, Benvenuto E, Baschieri S. Peptide display on Potato virus X: molecular features of the coat protein-fused peptide affecting cell-to-cell and phloem movement of chimeric virus particles. J Gen Virol 2006, 87:3103-3112. 10.1099/vir.0.82097-0, 16963770.
21. Chen TH, Chen TH, Hu CC, Liao JT, Lee CW, Liao JW, Lin MY, Liu HJ, Wang MY, Lin NS, Hsu YH. Induction of protective immunity in chickens immunized with plant-made chimeric bamboo mosaic virus particles expressing very virulent infectious bursal disease virus antigen. Virus Res 2012, 166:109-115. 10.1016/j.virusres.2012.02.021, 22406128.
22. Rioux G, Majeau N, Leclerc D. Mapping the surface-exposed regions of papaya mosaic virus nanoparticles. FEBS J 2012, 279:2004-2011. 10.1111/j.1742-4658.2012.08583.x, 22524169.
23. Leclerc D. Plant viral epitope display systems for vaccine development. Curr Top Microbiol Immunol in press.
24. Gandhi RT, Walker BD. Immunologic control of HIV-1. Annu Rev Med 2002, 53:149-172. 10.1146/annurev.med.53.082901.104011, 11818468.
25. Yerly D, Heckerman D, Allen TM, Chisholm JV, Faircloth K, Linde CH, Frahm N, Timm J, Pichler WJ, Cerny A, Brander C. Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance. J Virol 2008, 82:3147-3153. 10.1128/JVI.02252-07, 2258967, 18184704.
26. Carragher DM, Kaminski DA, Moquin A, Hartson L, Troy DR. A novel role for Non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J Immunol 2008, 181:4168-4176. 2590646, 18768874.
27. Savard C, Laliberté-Gagné ME, Bolduc M, Guérin A, Drouin K, Forget MA, Majeau N, Lapointe R, Leclerc D. Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen (Influenza NP). Vaccine 2012, 15:2535-2542.